0000357097-12-000001.txt : 20120518 0000357097-12-000001.hdr.sgml : 20120518 20120517174703 ACCESSION NUMBER: 0000357097-12-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120518 DATE AS OF CHANGE: 20120517 EFFECTIVENESS DATE: 20120518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-178470 FILM NUMBER: 12853180 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 D 1 primary_doc.xml X0705 D LIVE 0000357097 Fibrocell Science, Inc. 405 EAGLEVIEW BOULEVARD EXTON PA PENNSYLVANIA 19341 484-713-6000 DELAWARE ISOLAGEN INC AMERICAN FINANCIAL HOLDING INC /DE AMERICAN FINANCIAL HOLDING INC /CO Corporation true David Pernock 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Executive Officer Director Declan Daly 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Executive Officer Director Robert Langer 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Director Marc Mazur 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Director George J. Korkos 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Director Kelvin Moore 405 Eagleview Boulevard Exton PA PENNSYLVANIA 19341 Director Biotechnology $1 - $1,000,000 06 false 2012-05-14 false true true false 10000 John Carris Investments LLC 145767 None None 40 Wall Street 17th Floor New York NY NEW YORK 10005 All States true John Thomas Financial Inc. 40982 None None 14 Wall Street 23rd Floor New York NY NEW YORK 10005 All States true 12000000 3353000 8647000 Total Offering Amount includes $3,000,000 over-subscription amount. false 63 1200000 true 0 Assumes sale of total offering amount. Excludes (i) 3% expense allowance and (ii) warrants to purchase shares of common stock. 0 false Fibrocell Science, Inc. /s/ David Pernock David Pernock Chief Executive Officer 2012-05-17